Hematopoietic stem cell transplantation is associated with a severe immune deficiency. As a result, the patient is at high risk of infections. Innate immunity, including epithelial barriers, monocytes, granulocytes, and NK cells recovers within weeks after transplantation. By contrast, adaptive immunity recovers much slower. B- and T-cell counts normalize during the first months after transplantation, but in particular, T-cell immunity may remain impaired for years. During the last decade, much of the underlying mechanisms have been identified. These insights may provide new therapies to accelerate recovery
Background and aims. Allogeneic hematopoietic stem cells transplantation (HSCT) is strong curative t...
The interplay existing between immune reconstitution and patient outcome has been extensively demons...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
Hematopoietic stem cell transplantation is associated with a severe immune deficiency. As a result, ...
Innate immune cells are the first to recover after allogeneic hematopoietic cell transplantation (HC...
AbstractDefects in immune reconstitution after hematopoietic stem cell transplantation confer extrem...
After treatment with allogeneic hernatopoietic stem cell transplantation (HSCT) the patient suffers ...
AbstractDelayed immune reconstitution is 1 of the major contributions to the morbidity and mortality...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
Patients submitted to allogeneic stem cell transplantation have a prolonged immunodeficiency, extend...
Background/Aims Immune reconstitution following allogeneic hematopoietic stem cell transplantation (...
Approximatively 10,000 autologous hematopoietic stem cell transplants are performed worldwide each y...
Haploidentical hematopoietic stem cell transplantation (HSCT) offers the benefits of rapid and nearl...
International audienceLymphocytes are essential for microbial immunity, tumor surveillance, and tiss...
Defective immune reconstitution is a major barrier to successful hematopoietic cell transplantation ...
Background and aims. Allogeneic hematopoietic stem cells transplantation (HSCT) is strong curative t...
The interplay existing between immune reconstitution and patient outcome has been extensively demons...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...
Hematopoietic stem cell transplantation is associated with a severe immune deficiency. As a result, ...
Innate immune cells are the first to recover after allogeneic hematopoietic cell transplantation (HC...
AbstractDefects in immune reconstitution after hematopoietic stem cell transplantation confer extrem...
After treatment with allogeneic hernatopoietic stem cell transplantation (HSCT) the patient suffers ...
AbstractDelayed immune reconstitution is 1 of the major contributions to the morbidity and mortality...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
Patients submitted to allogeneic stem cell transplantation have a prolonged immunodeficiency, extend...
Background/Aims Immune reconstitution following allogeneic hematopoietic stem cell transplantation (...
Approximatively 10,000 autologous hematopoietic stem cell transplants are performed worldwide each y...
Haploidentical hematopoietic stem cell transplantation (HSCT) offers the benefits of rapid and nearl...
International audienceLymphocytes are essential for microbial immunity, tumor surveillance, and tiss...
Defective immune reconstitution is a major barrier to successful hematopoietic cell transplantation ...
Background and aims. Allogeneic hematopoietic stem cells transplantation (HSCT) is strong curative t...
The interplay existing between immune reconstitution and patient outcome has been extensively demons...
BACKGROUND: Immune reconstitution following transplantation in individuals who had received T-cell-d...